Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Harvest Gold Announces Annual General Meeting Results June 14, 2025 Bold Ventures June 14, 2025 Crypto Market Recap: Stablecoin Market Makes Headway, SharpLink Stocks Up on ETH June 14, 2025